Your brain chemistry and your drug metabolism share more genetic architecture than most people realize.
14 variants spanning dopamine, GABA, BDNF, adenosine, cortisol, and the CYP enzymes that determine how you process caffeine, antidepressants, antiplatelet drugs, and more.
The Biology
This is the most diverse domain in Varia's database, spanning two related areas: the genetic architecture of cognitive function and stress response, and the pharmacogenomics of drugs that act on or are metabolized by the brain and liver. Many of the same genes. COMT, CYP enzymes, ABCB1. Influence both neurochemistry and drug metabolism, which is why they are analyzed together.
What Varia Analyzes
COMT Val158Met (rs4680), governing prefrontal dopamine clearance and the Warrior/Worrier cognitive stress profile; GAD1 (rs3749034), governing GABA synthesis and cortical inhibitory tone; BDNF Val66Met (rs6265), which determines activity-dependent neuroplasticity and hippocampal function; CHRNA4 (rs1044396), nicotinic receptor signaling; CLOCK (rs1801260), circadian chronotype; ADORA2A (rs5751876), adenosine receptor sensitivity and caffeine-induced anxiety; FKBP5 (rs1360780), HPA axis stress response and PTSD risk; CYP1A2 (rs762551), caffeine metabolism speed; CYP2C19 (rs12248560), clopidogrel and antidepressant metabolism; CYP2C9 (rs1057910), warfarin and NSAID metabolism; ABCB1 (rs2032582), blood-brain barrier drug penetration; FAAH (rs324420), anandamide degradation rate; AKT1 (rs2494732), cannabis-psychosis risk; and DRD2 Taq1A (rs1800497), striatal dopamine receptor density.
Why It Matters
The pharmacogenomic findings in this domain are among the most immediately actionable in clinical medicine. CYP2C9 *3 and CYP2C19 17 have CPIC clinical guidelines with specific prescribing recommendations that your physician may not know to check without a test. The FKBP5 finding is the most replicated genetic predictor of PTSD risk following trauma and has direct implications for stress management and mental health monitoring. The COMT finding shapes how you process stress, perform cognitively, and respond to dopaminergic interventions.
Key sources
- Lachman HM, et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism. Pharmacogenetics. 1996.
- Egan MF, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003.
- SEARCH Collaborative Group. SLCO1B1 variants and statin-induced myopathy. N Engl J Med. 2008.
- Binder EB, et al. Association of FKBP5 polymorphisms and childhood abuse with risk of PTSD symptoms in adults. JAMA. 2008.
- Scott SA, et al. CPIC guidelines for CYP2C19 genotype and clopidogrel therapy. Clin Pharmacol Ther. 2011.